Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adductor canal block versus femoral nerve block on quadriceps strength and mobilization in healthy volunteers
2011-004285-15Phase 4Completed
- Sponsor
- Professor Jørgen Berg Dahl
- Start
- Sep 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ropivacaine in postoperative pain (3 arms), sponsored by Professor Jørgen Berg Dahl. Primary endpoint: Primary endpoint: difference in muscle strength between adductor canal block and placebo. Started Sep 2011; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2011-004285-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004285-15.